• Breakthrough in Malaria Vaccine Technology: Highly Effective 89% Efficacy Vaccine Emerges

  • Jan 11 2025
  • Length: 3 mins
  • Podcast

Breakthrough in Malaria Vaccine Technology: Highly Effective 89% Efficacy Vaccine Emerges

Listen for free

View show details

  • Summary

  • In the ongoing battle against malaria, recent developments have marked significant strides in the fight against this debilitating disease. A breakthrough in malaria vaccine technology has emerged with the introduction of a new, highly effective vaccine.

    A recent study published in _The New England Journal of Medicine_ has revealed a late-liver-stage malaria vaccine that achieves an unprecedented 89% efficacy. This vaccine, developed using a genetically attenuated (GA) _Plasmodium falciparum_ parasite, targets late-liver-stage antigens, a strategy that has shown remarkable promise. Unlike current vaccines such as RTS,S and R21, which target the circumsporozoite protein and offer only modest protection, this new vaccine boosts cellular immunity significantly, offering a new horizon in malaria eradication efforts[1].

    The World Health Organization (WHO) has been at the forefront of malaria vaccine initiatives, with a goal to produce an effective vaccine by 2025. The existing RTS,S vaccine, developed by GSK, has been in use since its recommendation by WHO in 2021. While it has shown a vaccine-attributable 13% drop in mortality among children and a substantial reduction in hospitalizations for severe malaria, it only prevents about 4 out of 10 infections. The R21 vaccine, another contender, has similar efficacy profiles, reducing malaria cases by more than half during the first year after vaccination[3][4].

    Despite these advancements, the need for more effective vaccines remains critical. Malaria continues to be a global emergency, claiming over a million lives annually, mostly children in Africa and Asia. The WHO, along with partners such as Gavi, the Vaccine Alliance, UNICEF, and others, has been working tirelessly to scale up malaria vaccination programs. As of 2024, 17 endemic countries have introduced malaria vaccines into their childhood immunization programs, with an additional 8 countries forecasted to follow suit in 2025[4].

    The distribution of these vaccines has been significant, with 18 million doses allocated to 12 African countries for the period 2023-2025. This initiative is expected to prevent tens of thousands of future deaths every year when combined with other malaria prevention interventions. The vaccines have already demonstrated high public health impact, particularly in reducing hospitalizations for severe malaria and improving access to other preventive measures like insecticide-treated nets[5].

    As the world inches closer to the WHO's 2025 goal for an effective malaria vaccine, these recent developments offer a beacon of hope in the fight against this devastating disease. With continued research and the scaling up of vaccination programs, there is a growing optimism that malaria can be significantly controlled, if not eradicated, in the near future.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Breakthrough in Malaria Vaccine Technology: Highly Effective 89% Efficacy Vaccine Emerges

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available